HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome.

AbstractOBJECTIVE:
To evaluate the effect of N-acetyl-cysteine (NAC) on insulin secretion and peripheral insulin resistance in subjects with polycystic ovary syndrome (PCOS).
DESIGN:
Prospective data analysis.
SETTING:
Volunteer women in an academic research environment.
PATIENT(S):
Six lean and 31 obese subjects, aged 19-33 years.
INTERVENTION(S):
Patients were treated for 5-6 weeks with NAC at a dose of 1.8 g/day orally. A dose of 3 g/day was arbitrarily chosen for massively obese subjects. Six of 31 obese patients with PCOS were treated with placebo and served as controls.
MAIN OUTCOME MEASURE(S):
Before and after the treatment period, the hormonal and lipid blood profile and insulin sensitivity, assessed by an hyperinsulinemic euglycemic clamp, were evaluated and an oral glucose tolerance test (OGTT) was performed.
RESULT(S):
Fasting glucose, fasting insulin, and glucose area under curve (AUC) were unchanged after treatment. Insulin AUC after OGTT was significantly reduced, and the peripheral insulin sensitivity increased after NAC administration, whereas the hepatic insulin extraction was unaffected. The NAC treatment induced a significant fall in T levels and in free androgen index values (P<.05). In analyzing patients according to their insulinemic response to OGTT, normoinsulinemic subjects and placebo-treated patients did not show any modification of the above parameters, whereas a significant improvement was observed in hyperinsulinemic subjects.
CONCLUSION(S):
NAC may be a new treatment for the improvement of insulin circulating levels and insulin sensitivity in hyperinsulinemic patients with polycystic ovary syndrome.
AuthorsAnna Maria Fulghesu, Mario Ciampelli, Giuseppe Muzj, Chiara Belosi, Luigi Selvaggi, Gian Franco Ayala, Antonio Lanzone
JournalFertility and sterility (Fertil Steril) Vol. 77 Issue 6 Pg. 1128-35 (Jun 2002) ISSN: 0015-0282 [Print] United States
PMID12057717 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Androgens
  • Insulin
  • Testosterone
  • Acetylcysteine
Topics
  • Acetylcysteine (administration & dosage, therapeutic use)
  • Adult
  • Androgens (blood)
  • Drug Administration Schedule
  • Female
  • Glucose Tolerance Test
  • Humans
  • Hyperinsulinism (blood)
  • Insulin (blood, metabolism)
  • Insulin Resistance (physiology)
  • Liver (metabolism)
  • Polycystic Ovary Syndrome (drug therapy, physiopathology)
  • Prospective Studies
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: